Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1308 of 5804
-
Microchip implanted in tumors could reveal best drug for each patient
Knowledge-focused Recruiting nowThis research is being done to study the safety and feasibility of implanting and retrieving a microdevice that releases microdoses of 19 specific drugs or drug combinations as a possible tool to evaluate the effectiveness of several cancer drugs against metastatic renal cell car…
Phase: PHASE1 • Sponsor: Oliver Jonas • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Could a new scan unlock better breast cancer treatment?
Diagnosis Recruiting nowA strategy to target the oncogenic receptor HER2 using a version of the anti-HER2 therapeutic antibody trastuzumab coupled to desferrioxamine (DFO) and radiolabeled with zirconium-89 (\[89Zr\]-DFO-trastuzumab) has been successfully evaluated in our group in preclinical settings. …
Phase: PHASE1, PHASE2 • Sponsor: Centre de recherche du Centre hospitalier universitaire de Sherbrooke • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
Donor cartilage plugs aim to fix damaged knees
Disease control Recruiting nowThe primary objective of this study is to obtain evidence of the effectiveness of Cryopreserved Osteochondral Allograft Core in the treatment of osteochondral lesions on the femoral condyle.
Phase: NA • Sponsor: AlloSource • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
VR brain training shows promise for kids with ADHD
Symptom relief OngoingThe study aims to explore whether the treatment using fNIRS-based neurofeedback training for children with attention-deficit/hyperactivity disorder (ADHD) is useful. Furthermore, the study hopes to evaluate whether the use of virtual reality (VR) technology will have an impact on…
Phase: NA • Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New scan may tell rectal cancer patients if they can skip surgery
Knowledge-focused CompletedThe combination of short course radiotherapy and immunotherapy helps to increase the proportion of pathological complete response after neoadjuvant therapy, providing more patients with the opportunity for organ preservation. However, there is no accurate and unified cCR diagnost…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
New adaptive radiation aims to hit cancer harder, spare healthy tissue
Disease control Recruiting nowThe goal of this clinical trial is to learn if adaptive radiation boost works to treat genitourinary cancers, esp. in the context of prostate cancer patients with post-prostatectomy local relapse and bladder cancer patients with bladder-conserving treatment. It will also learn ab…
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
5,000 couples join study to uncover hidden factors in IVF success
Knowledge-focused Recruiting nowThis large-scale study aims to understand how everyday environment and lifestyle may affect the success of fertility treatments like IVF. The main idea is that exposure to certain environmental chemicals (e.g., from plastics or air pollution) and personal habits (e.g., diet, stre…
Sponsor: The Third Xiangya Hospital of Central South University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Can a gas protect your kidneys during heart surgery?
Disease control CompletedThe goal of this clinical trial is to determine the effectiveness of exogenous nitric oxide therapy in reducing the occurrence of acute kidney injury in patients with acute type A aortic dissection. Additionally, it aims to assess the safety of exogenous nitric oxide therapy.
Phase: PHASE4 • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New combo aims to stall aggressive brain tumors when surgery and radiation fail
Disease control Recruiting nowMeningioma, the most common intracranial primary tumor of the central nervous system predominantly affects people in their fifties. Meningiomas are generally subdivided into two entities: a priori non-aggressive meningiomas (grade 1), and meningiomas at high risk of aggressive be…
Phase: PHASE2 • Sponsor: Central Hospital, Nancy, France • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Can an eczema drug stop the itch of lichen simplex chronicus?
Symptom relief OngoingThis is a parallel, Phase 3, 2-arm study for treatment. The purpose of this study is to measure improvement in pruritus with dupilumab subcutaneous injections compared with placebo injections in male and female participants aged at least 18 years with LSC. Study details include:…
Phase: PHASE3 • Sponsor: Sanofi • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Tiny beads aim to quiet arthritic knees without surgery
Symptom relief OngoingAn open label, prospective, two-arm, multicenter, randomized controlled trial comparing SakuraBead genicular artery embolization (GAE) with a control (corticosteroid injection).
Phase: NA • Sponsor: CrannMed • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Sleep therapy may ease psychosis in Treatment-Resistant schizophrenia
Symptom relief Recruiting nowUsing a randomized controlled design, the project aims to test if cognitive behavioral therapy interventions specifically targeting sleep disorders can significantly lessen the burden of the disrupted sleep in patients with treatment resistant schizophrenia (TRS) and by proxy lea…
Phase: NA • Sponsor: Jimmi Nielsen • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Texts and peers could help LGBTQ+ youth beat HIV in nigeria
Disease control Recruiting nowThe study will adapt and test a combination peer navigation and mHealth approach, Intensive Combination Approach to Rollback the Epidemic in Nigeria (iCARE Nigeria), to improve HIV treatment engagement, medication adherence and viral suppression among YMSM and YTW, ages 15-29.
Phase: NA • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Breathing pure oxygen during an MRI may reveal whether liver cancer treatment is working
Knowledge-focused ENROLLING_BY_INVITATIONTo predict response of HCC to TACE using dynamic oxygen-enhanced (dOE)-MRI for assessment of the level of tumor hypoxia before and after treatment.
Phase: NA • Sponsor: Université de Montréal • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
New hope for advanced bladder cancer? drug targets specific gene mutations
Disease control Recruiting nowThis phase II trial tests how well pemetrexed works in treating patients with urothelial bladder cancer and other solid tumors that have spread from where they first started (primary site) to other places in the body (metastatic) with mutations that result in a loss of function i…
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a Pill-Sized camera replace some colonoscopies?
Diagnosis Recruiting nowThe Department of Surgery at Odense University Hospital (OUH) carries out approximately 10,000 colonoscopies each year, and this number is continuously increasing. Since 2014, the screening for colorectal cancer (CRC) has resulted in a significant increase in the colonoscopy work…
Phase: NA • Sponsor: Odense University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
New BTK-Degrader cocktail takes on Hard-to-Treat blood cancers
Disease control Recruiting nowThe purpose of this study is to measure the safety, preliminary antitumor activity, pharmacokinetics, and pharmacodynamics with BGB-16673 in combination with other agents in participants with relapsed or refractory (R/R) B-cell malignancies. This study is structured as a master p…
Phase: PHASE1, PHASE2 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New therapy aims to boost teen recovery from substance use
Disease control Recruiting nowThis is a Phase II parallel group randomized controlled trial with 294 adolescents (age: 14-21 years) with alcohol and other drug \[AOD\] use disorder (hereafter substance use disorder), that compares two different active psychosocial interventions designed to address adolescent …
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New eye drug SCT520FF hopes to tackle wet AMD
Disease control Recruiting nowMulticenter, open-label, multi-dose study to evaluate the safety and tolerability in patients with nAMD treated with SCT520FF.
Phase: PHASE1, PHASE2 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Jun 26, 2026 14:00 UTC
-
New drug shows promise for Long-Term control of chronic hives
Disease control OngoingPhase 2, open-label, extension study to evaluate the long-term safety, clinical activity, and pharmacodynamics of briquilimab in participants previously enrolled in a Jasper sponsored CU clinical trial.
Phase: PHASE2 • Sponsor: Jasper Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC